- 5-Benzyloxy-T
- 5-Benzyloxytryptamine
Peroutka, SJ; McCarthy, BG; Guan, X. 5-Benzyloxytryptamine: a relatively selective 5-hydroxytryptamine1D/1B agent Life Sci., 1 Jan 1991, 49 (6), 409–418. 556 kB. https://doi.org/10.1016/0024-3205(91)90582-V
Lyon, RA; Titeler, M; Seggel, MR; Glennon, RA. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens Eur. J. Pharmacol., 19 Jan 1988, 145 (3), 291–297. 533 kB. https://doi.org/10.1016/0014-2999(88)90432-3
Prainer, B. Tryptamin-derivate als 5-HT4-rezeptorliganden: synthese und in-vitro-pharmakologie dissertation Ph. D. Thesis, Universität Regensburg, Regensburg, Germany, 21 Jul 2008. 2.2 MB. #16 In German. MS,NMR
Mesley, RJ; Evans, WH. Infrared identification of some hallucinogenic derivatives of tryptamine and amphetamine J. Pharm. Pharmacol., 1 May 1970, 22 (5), 321–332. 775 kB. https://doi.org/10.1111/j.2042-7158.1970.tb08533.x #5-Benzyloxytryptamine IR
Schumacher, M. Chirale arylmethoxytryptamine als 5-HT2B-Rezeptoragonisten: synthese, analytik und in-vitro-pharmakologie Ph. D. Thesis, Universität Regensburg, Würzburg, Germany, 16 Mar 2007. 2.2 MB. #14 In German. MS,NMR,other
Klein, MT; Dukat, M; Glennon, RA; Teitler, M. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: A comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships J. Pharmacol. Exp. Ther., 1 Jun 2011, 337 (3), 860–867. 1.7 MB. https://doi.org/10.1124/jpet.111.179606 #4